biotechtrader.wordpress.com biotechtrader.wordpress.com

BIOTECHTRADER.WORDPRESS.COM

Biotechtrader | Just another WordPress.com weblog

Just another WordPress.com weblog

http://biotechtrader.wordpress.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR BIOTECHTRADER.WORDPRESS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

January

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 12 reviews
5 star
2
4 star
6
3 star
2
2 star
0
1 star
2

Hey there! Start your review of biotechtrader.wordpress.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.5 seconds

FAVICON PREVIEW

  • biotechtrader.wordpress.com

    16x16

  • biotechtrader.wordpress.com

    32x32

CONTACTS AT BIOTECHTRADER.WORDPRESS.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Biotechtrader | Just another WordPress.com weblog | biotechtrader.wordpress.com Reviews
<META>
DESCRIPTION
Just another WordPress.com weblog
<META>
KEYWORDS
1 biotechtrader
2 fda calendar
3 phase ii/iii database
4 spref=tw
5 advertisements
6 leave a comment
7 immunocellular therapeutics
8 rxi pharmaceuticals
9 inc nasdaq oxgn
10 http / tinyurl.com/3vbocfe
CONTENT
Page content here
KEYWORDS ON
PAGE
biotechtrader,fda calendar,phase ii/iii database,spref=tw,advertisements,leave a comment,immunocellular therapeutics,rxi pharmaceuticals,inc nasdaq oxgn,http / tinyurl.com/3vbocfe,nasdaq pcyc,http / tinyurl.com/6el7az2,gtxi,http / tinyurl.com/3kq2z9x
SERVER
nginx
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Biotechtrader | Just another WordPress.com weblog | biotechtrader.wordpress.com Reviews

https://biotechtrader.wordpress.com

Just another WordPress.com weblog

INTERNAL PAGES

biotechtrader.wordpress.com biotechtrader.wordpress.com
1

$CLSN Announces DSMB Recommends Advancing DIGNITY Study of ThermoDox(R) Into Phase II | Biotechtrader

https://biotechtrader.wordpress.com/2011/06/08/clsn-announces-dsmb-recommends-advancing-dignity-study-of-thermodoxr-into-phase-ii

CLSN Announces DSMB Recommends Advancing DIGNITY Study of ThermoDox(R) Into Phase II. June 8, 2011 at 5:18 am. 06/08/11 — Celsion Corporation (NASDAQ: CLSN),. Via Celsion Announces Drug Safety Monitoring Board Recommends Advancing DIGNITY Study of ThermoDox(R) in Recurrent Chest Wall Breast Cancer Into Phase II SYS-CON MEDIA. Entry filed under: Phase II News. RXii Pharmaceuticals phase 2 results NeuVax. Leave a Reply Cancel reply. Enter your comment here. Address never made public). RT @ Busiter ESPN.

2

FDA Calendar | Biotechtrader

https://biotechtrader.wordpress.com/fda-calendar

Leave a Reply Cancel reply. Enter your comment here. Fill in your details below or click an icon to log in:. Address never made public). You are commenting using your WordPress.com account. ( Log Out. You are commenting using your Twitter account. ( Log Out. You are commenting using your Facebook account. ( Log Out. You are commenting using your Google account. ( Log Out. Notify me of new comments via email. Subscribe to the comments via RSS Feed. Create a free website or blog at WordPress.com.

3

$RXii Pharmaceuticals phase 2 results NeuVax | Biotechtrader

https://biotechtrader.wordpress.com/2011/06/08/rxii-pharmaceuticals-phase-2-results-neuvax

RXii Pharmaceuticals phase 2 results NeuVax. June 8, 2011 at 5:06 am. Via RXi Pharmaceuticals Corp (RXII.O) Key Developments Reuters.com. Entry filed under: Phase II News. OXGN $PCYC Phase II news from 6/6/2011. CLSN Announces DSMB Recommends Advancing DIGNITY Study of ThermoDox(R) Into Phase II. Leave a Reply Cancel reply. Enter your comment here. Fill in your details below or click an icon to log in:. Address never made public). You are commenting using your WordPress.com account. ( Log Out.

4

Phase II/III Database | Biotechtrader

https://biotechtrader.wordpress.com/phase-ii-iii-database

I will use this page to track phase II and Phase III stocks under $5 with upcoming updates/data/catalysts. Leave a Reply Cancel reply. Enter your comment here. Fill in your details below or click an icon to log in:. Address never made public). You are commenting using your WordPress.com account. ( Log Out. You are commenting using your Twitter account. ( Log Out. You are commenting using your Facebook account. ( Log Out. You are commenting using your Google account. ( Log Out.

5

Watch List for 6/13 | Biotechtrader

https://biotechtrader.wordpress.com/2011/06/12/watch-list-for-613

Watch List for 6/13. June 12, 2011 at 6:56 pm. Will be moving my blog here soon –. Http:/ biotechtrader34.blogspot.com/2011/06/my-watchlist-for-week-of-613.html? Entry filed under: Uncategorized. IMUC $AVII Phase 2 News for today. Leave a Reply Cancel reply. Enter your comment here. Fill in your details below or click an icon to log in:. Address never made public). You are commenting using your WordPress.com account. ( Log Out. You are commenting using your Twitter account. ( Log Out. RT @ Busiter ESPN.

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL PAGES IN THIS WEBSITE

10

SOCIAL ENGAGEMENT



OTHER SITES

biotechtr.com biotechtr.com

DreamHost

DreamHost Imagine the Web, Your Way. Biotechtr.com Coming Soon! The DreamHost customer who owns biotechtr.com has not yet uploaded their website or has chosen to leave this holding page active. If you are the owner of this domain, you'll find your login information contained within the emails sent to you when your account was activated. Once logged in, you'll be able to delete this page (quickstart.html) and upload your new site. Here are some helpful links for getting started:.

biotechtrade.fr biotechtrade.fr

Biotech Trade —

Brevets en Europe, aux Etats-Unis et en Chine pour Masterflow. 12 février 2015 at 9 h 49 min. VEXIM (FR0011072602 ALVXM) annonce aujourd’hui le renforcement significatif de la propriété intellectuelle de MASTERFLOW , son système d’injection de ciment orthopédique haute performance. Prenant appui sur un ensemble de technologies uniques et innovantes, ce nouveau dispositif garantit une précision, un contrôle et une sécurité optimale lors de […]. Résultats positifs pour les fibroadénomes du sein. Carbios (A...

biotechtrader.blogspot.com biotechtrader.blogspot.com

The Biotech Trader

Long and Short Trading Opportunities in the Biotech Industry by Ivan Mutaftchiev. Tuesday, July 5, 2011. This Blog Has Moved. Ivan Mutaftchiev's blog has moved to. Visit the new blog for real-time Buy or Sell trading alerts! Tuesday, July 05, 2011. Wednesday, November 25, 2009. Biotech Stocks - Beware of The Covered Call Trap. Sounds like a good plan right? I mean, how can you lose? And here is another - GTX Inc (GTXI) traded around $12.50 on September 21. One of the bests calls to sell was the N...In th...

biotechtrader.com biotechtrader.com

www.biotechtrader.com

biotechtrader.info biotechtrader.info

biotect traders

Advisory Committee and PDUFA Date Activity. Generic Name Trade Name Originator Indication Date. Fentanyl SL Spray Insys Therapeutics Inc cancer pain 01/04/2012 PDUFA. Progesterone PROCHIEVE Columbia Laboratories Inc reduction of risk of preterm birth 01/20/2012 AdComm. Dapagliflozin Bristol-Myers Squibb Co. type 2 diabetes mellitus 01/28/2012 PDUFA. Exenatide Bydureon Amylin Pharmaceuticals Inc type 2 diabetes 01/28/2012 PDUFA. Phentermine and topiramate Qnexa VIVUS INC obesity 02/22/2012 AdComm. Pegines...

biotechtrader.wordpress.com biotechtrader.wordpress.com

Biotechtrader | Just another WordPress.com weblog

Watch List for 6/13. Will be moving my blog here soon –. Http:/ biotechtrader34.blogspot.com/2011/06/my-watchlist-for-week-of-613.html? June 12, 2011 at 6:56 pm. IMUC $AVII Phase 2 News for today. OTC:IMUC) said Thursday it has expanded the number of sites for its phase two clinical trial of ICT-107, a potential vaccine treatment for brain cancer. The vaccine uses cancer stem cells to target multiple tumour-associated antigens, which generate an antibody response from the body’s own immune system. Via AV...

biotechtraderhandbook.com biotechtraderhandbook.com

THE BIOTECH TRADER HANDBOOK

THE BIOTECH TRADER HANDBOOK. Sunday, October 9, 2011. Transitioning to Chimera Research Group. To All Visitors and Subscribers,. I want to thank you for visiting biotechtraderhandbook.com over the past few years. It has been my pleasure to provide what I hope has been insightful trading strategies for the biotech and pharmaceutical sectors. Posted by Tony Pelz. Wednesday, March 30, 2011. Trading XenoPort's PDUFA Event. XenoPort Inc. (XNPT) is set to receive notification from the FDA on April 6 whethe...

biotechtrading.com biotechtrading.com

Biotech Trading

Skip to main content. This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Drag or click the correct shape to the grey "drop area".

biotechtraining.blogspot.com biotechtraining.blogspot.com

Biotech Training

Monday, August 13, 2007. Source : http:/ biospectrumindia.ciol.com/content/student/104051501.asp. The objective of BITP is to provide practical exposure to candidates who wish to start their career after post-graduation but do not have the requisite experience in biotechnology. This program orients them to the needs of the industry and makes them more relevant and acceptable for placement. The program is launched every year generally in the months of July/August. Bangalore Genei, a Bangalore-based key ma...

biotechtraining.com biotechtraining.com

Price Request - BuyDomains

Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.

biotechtraining.net biotechtraining.net

biotechtraining

Monica Ranes-Goldberg, Ph.D. Onsite Training in Immunology, Cancer Biology, and Infectious Diseases.